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The development of oligodendrocytes, the myelinating cells of the vertebrate CNS, is regulated by a
cohort of growth factors and transcription factors. Less is known about the signaling pathways that
integrate extracellular signals with intracellular transcriptional regulators to control oligodendrocyte
development. Cyclin dependent kinase 5 (Cdk5) and its co-activators play critical roles in the regulation
of neuronal differentiation, cortical lamination, neuronal cell migration and axon outgrowth. Here we
demonstrate a previously unrecognized function of Cdk5 in regulating oligodendrocyte maturation and
myelination. During late embryonic development Cdk5 null animals displayed a reduction in the number
of MBP+ cells in the spinal cord, but no difference in the number of OPCs. To determine whether the
reduction of oligodendrocytes reﬂected a cell-intrinsic loss of Cdk5, it was selectively deleted from Olig1+
oligodendrocyte lineage cells. In Olig1Cre/+; Cdk5ﬂ/ﬂ conditional mutants, reduced levels of expression of
MBP and PLP mRNA were observed throughout the CNS and ultrastructural analyses demonstrated a
signiﬁcant reduction in the proportion of myelinated axons in the optic nerve and spinal cord.
Pharmacological inhibition or RNAi knockdown of Cdk5 in vitro resulted in the reduction in oligoden-
drocyte maturation, but had no effect on OPC cell proliferation. Conversely, over-expression of Cdk5
promoted oligodendrocyte maturation and enhanced process outgrowth. Consistent with this data, Cdk5−/−
oligodendrocytes developed signiﬁcantly fewer primary processes and branches than control cells.
Together, these ﬁndings suggest that Cdk5 function as a signaling integrator to regulate oligodendrocyte
maturation and myelination.
& 2013 Elsevier Inc. All rights reserved.Introduction
Oligodendrocytes (OLs) the myelin-forming cells of CNS and are
derived from oligodendrocyte precursor cells (OPCs) (Raff et al.,
1984; Rowitch, 2004). Oligodendrocyte precursors originate in
distinct locations and subsequently migrate throughout CNSll rights reserved.
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0 Adelbert Road Suite 329,
368 4650.
(R. Lu),
g Kong University of Science
g.before differentiating into oligodendrocytes and myelinating tar-
get axons (Miller, 1996; Pringle and Richardson, 1993; Sherman
and Brophy, 2005). Perturbed myelination during development or
failure of remyelination in demyelinating diseases such as multiple
sclerosis (MS) leads to axonal damage and irreversible functional
loss. Oligodendrocyte development is regulated by a wide range of
growth factors (PDGF, neuregulin-1, FGF2), signaling pathways
(Shh, LINGO-1, BMP, Wnt and notch signaling) and transcription
factors (Olig2, Nkx2.2, Sox10 and MRF) (Barres et al., 1992; Calver
et al., 1998; Emery et al., 2009; Fuller et al., 2007; Lu et al., 2000;
McKinnon et al., 1990; McKinnon et al., 1993; Mi et al., 2008;
Miller et al., 2004; Richardson et al., 1988; Shimizu et al., 2005;
Wang et al., 1998). How the roles of these different components
are coordinated to regulate the conversion of proliferating OPCs to
OLs and subsequent myelination is currently unclear.
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with signiﬁcant homology to cell cycle related Cdks (Hellmich
et al., 1992) but has not been implicated in regulating cell cycle
progression (Vermeulen et al., 2003). Although Cdk5 is expressed
in virtually all tissues, its activity appears to be largely restricted to
the nervous system since its critical co-activators, p35 and p39 are
highly expressed in the CNS (Lew et al., 1994; Tsai et al., 1994).
During neuronal development Cdk5 is important in regulation of
cortical lamination, neuronal migration, differentiation and synap-
togenesis (Gilmore and Herrup, 2001; Gilmore et al., 1998;
Ohshima et al., 1996; Patrick et al., 1998) and loss of Cdk5 leads
to deﬁcits of neuronal development and neuronal cell death
(Alexander et al., 2004; Cicero and Herrup, 2005). The regulation
of Cdk5 activity is complex and may involve the calpain-mediated
proteolysis of its co-activators p35 and p39 (Kamei et al., 2007).
Alternatively, the non-receptor tyrosine kinases Abl and Fyn,
members of the Src-family of tyrosine kinases, phosphorylate
Cdk5 at Tyr15, which may modulate its activity (Sasaki et al.,
2002; Zukerberg et al., 2000). Not all neuronal cell types are
dependent on Cdk5 during development and the spinal cord is less
affected than forebrain by the lack of Cdk5 (Yip et al., 2007).
During OPC differentiation Cdk5 activity has been proposed to
increase and through the phosphorylation of paxillin (Miyamoto
et al., 2007), as well as WAVE2 regulate OPC migration (Miyamoto
et al., 2008). In addition, Emx1-Cre mediated Cdk5 conditional
mice, showed hypomyelination (He et al., 2011). It is unclear,
however whether hypomyelination in these animals reﬂects Cdk5
loss in oligodendrocyte lineage cells or is secondary to its loss in
neurons.
Here we show that Cdk5 expression in the oligodendrocyte
lineage is required for the maturation of oligodendrocytes and
normal myelination. In Cdk5 knockout animals there is a reduction
in the number and distribution of spinal cord MBP+ cells. Condi-
tional deletion of Cdk5 from Olig1+ cells resulted in a reduction of
MBP and PLP mRNA expression in the CNS and a reduction in the
number of myelinated axons in the optic nerve, while inhibition of
Cdk5 delayed OPC differentiation and over-expression promoted
OPC differentiation in the absence of changes in cell proliferation.
These data suggest that Cdk5 is required for the normal develop-
ment of mature oligodendrocyte and myelination in the develop-
ing CNS and provide insights to speed the development of re-
myelination strategies in demyelinating diseases such as MS.Materials and methods
Antibodies
The primary antibodies used in the study include: rabbit
polyclonal Cdk5 (Santa Cruz, CA, SC19); mouse monoclonal anti-
bodies of A2B5, O4 and O1 as described previously (Gao et al.,
2006; Tsai et al., 2006); rabbit polyclonal antibody anti-NG2
(Millipore, AB5320); rabbit polyclonal Olig2 antibody (Millipore,
AB9610); A mouse monoclonal antibody against MBP (Covance,
Princeton, NJ) and a polyclonal antibody against EGFP (Invitrogen,
A11122).
Animals
Animals were maintained in the Animal Resource Center of Case
Western Reserve University School of Medicine using procedures
approved by the Institutional Animal Care and Use Committee
of the University. Cdk5 heterozygous mice on a C57BL6/J genetic
background were obtained from Dr. Herrup (Rutgers University)
and individual offspring were genotyped by PCR as described
previously (Cicero and Herrup, 2005). Studies involving theOlig1Cre/+; Cdk5ﬂ/ﬂ CKO mice were conducted at UT Southwestern.
These mice were derived by crossing Cdk5ﬂ/ﬂ mice (Benavides et al.,
2007; Hawasli et al., 2007) with Olig1Cre/Cre mice to generate double
transgenic Olig1cre/+; Cdk5ﬂ/+ animals which were intercrossed to
Cdk5ﬂ/ﬂ mice to produce a conditional knockout mouse of Olig1Cre/+;
Cdk5ﬂ/ﬂ, in which Cdk5 is deleted exclusively in Olig1+ oligoden-
drocyte lineage cells. Previous studies demonstrated that Olig1 was
initially detected in the murine spinal cord at E8.5 at the ventral
midline in a cohort of cells that generate both to OPCs and motor
neurons (Lu et al., 2002). All animals were genotyped by PCR as
described previously (Lu et al., 2002; Xin et al., 2005). Both Olig1+/+;
Cdk5 ﬂ/+ (WT; Cdk5 ﬂ/+) and heterozygotes Olig1Cre/+;Cdk5ﬂ/+ served
as controls since the heterozygote of Olig1Cre/+;Cdk5ﬂ/+ has no
abnormal phenotype compared to Olig1+/+;Cdk5 ﬂ/+ wild type
animal.
For quantiﬁcation of oligodendrocytes P7 and P14 Olig1Cre/+;
Cdk5ﬂ/ﬂ CKO and age-matched wild type littermate animals were
anesthetized using ketamine/xylazine, the brains and the spinal
cords were dissected and ﬁxed in 4% paraformaldehyde at 4 1C
overnight followed in 20% sucrose in PBS overnight. Coronal
sections of brains and spinal cords were cryosectioned at 16 μm
and prepared for in situ hybridization.
BrdU injection and immunohistochemistry for frozen cryosections
Animals were injected with 5'-bromo-2'-deoxyuridine (BrdU)
(Sigma, St. Louis, MO, 100 mg/g, i.p.) 2 h before sacriﬁce. Embryos
were taken at embryonic day E18, genotyped and ﬁxed in 4%
paraformaldehyde at 4 1C overnight followed by equilibration in
20% sucrose. Coronal sections of spinal cord were cut at 20 mm on a
Leica cryostat. For double labeling of BrdU and OPC or OL cell
markers, sections were blocked with 5% normal goat serum (NGS)
in 0.3% triton in PBS for 1 h, followed by incubation in primary
antibody, and subsequently secondary antibody conjugated with
Alexa 488 or 596. For BrdU labeling, sections were permeabilized
with 2 N HCL for 30 min followed by incubation with anti-BrdU
antibody and Alexa conjugated secondary antibodies.
RNA in situ hybridization
Digoxigenin-labeled riboprobes against Mbp, Plp1, PdgfαR were
used to perform RNA in situ hybridization as described previously
(Lu et al., 2002). For analysis of proliferation, the conjunction of
PdgfαR in situ hybridization and immunostaining for BrdU were
performed as described previously (Xin et al., 2005). Controls and
Olig1 Cre/+;Cdk5ﬂ/ﬂ CKO at P7 and P14 were injected (i.p.) with
100 mg/kg BrdU for 4 h before sacriﬁce of the animals. Sections
were hybridized with the PdgfαR riboprobe (Lu et al., 2002). After
ﬁxation with 4% paraformaldehyde for 15 min, sections were
treated with 2 N HCl in PBS for 30 min at 37 1C and rinsed in
PBS. Sections were blocked with 0.1% NP-40 and 5% normal goat
serum in PBS for 1 h at room temperature. After addition of rat
polyclonal anti-BrdU antibody (1:100 dilution; Sigma, St. Louis,
MO) at 4 1C overnight, the sections were treated using a Vectastain
Elite ABC kit (Vector Laboratories, Burlingame, CA); HRP was
detected with diaminobenzidine (Sigma, St. Louis, MO) according
to the manufacturer's instructions.
Tissue preparation for EM analysis
Both spinal cord and optic nerve of Olig1Cre/+; Cdk5ﬂ/ﬂ CKO and
control mice were dissected at P14 and were ﬁxed in glutaralde-
hyde (2%) and paraformaldehyde (4%) followed by 1% OsO4, block
stained with saturated uranyl acetate, dehydrated through graded
alcohols and embedded in Epon 812. Sections were cut in a
plane parallel to the surface of the slice. To assess the extent of
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examined on a Jeol 100CX electron microscope at 80 kV. To
compare the relative thickness of myelin sheaths in the Cdk5 cKO
and WT animals the g ratios were calculated from at least 35–50
axons in the anterior funiculus of the spinal cord. The proportion
of myelinated axons was quantiﬁed from the same region of the
spinal cord and optic nerve in control and transgenic animals and
a minimum of 35–50 axons were assayed.
Preparation and characterization of spinal cord cell cultures
Mixed brain or spinal cord cell cultures were prepared either from
E18 Cdk5 KO or postnatal day 2 (P2) Sprague-Dawley rat pups (SD,
Harland Animal Resource, USA) as previously described (Kerstetter
et al., 2009) and plated at a density of 2104 cells/coverslip in DMEM
supplemented with 1% FBS-c (HyClone), 10 ng/ml PDGF (PDGF-AA,
Sigma) and N2 supplement (Invitrogen). Cultures were maintained at
37 1C/5% CO2 and the growth mediumwas changed every second day.
Highly enriched populations A2B5+ or O4+ OPCs were prepared
from spinal cord of P1 SD rat pups by immunopanning as previously
described (Robinson and Miller, 1996).
Spinal cord explant cultures were prepared from E18 Cdk5−/−
and WT mouse embryos. Cervical and thoracic segments of the
spinal cord were chopped into 1–2 mm tissue pieces and transferred
to PLL-coated coverslips. BD MatrigelTM Basement Membrane Matrix,
Growth Factor Reduced (Cat# 354230, BD Bioscience) was applied
(50–100 μl/coverslip) followed by incubation at 37 1C (Fok-Seang
and Miller, 1994). Explant cultures were grown in standard media
with 1% FBS-c (HyClone), 10 ng/ml PDGF (PDGF-AA, Sigma) and N2
supplement (Invitrogen). In some experiments PDGF (50 ng/ml)
was added.
Labeling with monoclonal antibodies A2B5 (1:3), O4 (1:4) and O1
(1:4) was performed on live cells as previously described (Nishiyama
et al., 1999; Zhang and Miller, 1996). Cells were incubated in primary
antibody for 30 min followed by ﬂuorescence-conjugated Alexa
mouse IgM 488 or 596 secondary antibodies. Cells were then ﬁxed
in 4% paraformaldehyde for 20 min. For double labeling, second
primary antibodies – rabbit Cdk5 (1:200), mouse MBP (1:500) or
rabbit EGFP (1:500) were applied to cells and incubated overnight at
4 1C followed by incubationwith ﬂuorescence-conjugated secondary
Alexa 488 or 596-conjugated antibody.
Transfection of OPCs in spinal cord cell cultures
Cells were collected from dissociated spinal cord cultures and
centrifuged at 100 rpm at room temperature. The cell pellet was
re-suspended to a density of 5106 cells/100 ml in OPC Nucleofec-
tion solution (Amaxa rat oligodendrocytes Nucleofector kit,
Amaxa). 100 ml of Nucleofection solution containing 5106 cells
was added to RNAi for Cdk5 (4 mg/ml) or Cdk5-EGFP plasmids
(2 mg/ml) as well as control pEGFP-C1 plasmid or a scrambled
siRNA plasmid followed by electroporation using the Amaxa
nucleofection apparatus with the program O-17 (Amaxa) accord-
ing to the manufacturer's instructions. Cells were plated on
PLL-coated coverslip at 2104/coverslip and grown for 2– 4 days
in growth media as described above.
Quantiﬁcation and Statistics
Cell counts: Blinded cell counts of cultured cells and labeled
cells in age and location matched frozen sections were performed
on at least three coverslips or sections per condition from three
separate experiments using a Leica Fluorescence microscope with
a 20 or 40 objective lens and a reticule (1010 grid). For each
experiment, seven ﬁelds were randomly selected on each coverslip
or section. The total number of immunopositive cells (A2B5+, O4+,O1+ or MBP+) and the total number of DAPI stained cells were
calculated and compared between treated cultures and non-
treated controls. For quantiﬁcation of MBP immunostaining in
the tissue sections, the average of total numbers of MBP+ cells for
per spinal cord section was calculated and compared between
Cdk5−/− and wild type animals at E18. To quantify the proportion of
myelinated axons in the spinal cord, the anterior funiculus region
in ventral spinal cord was selected and the at least 200 axons
assayed in three animals of each genotype. To quantify the effects
of loss of Cdk5 on the cytoarchitecture of oligodendrocytes the
number of primary processes and the number of branches were
assayed in the mixed brain cell cultures of WT and Cdk5−/− cells
(E18+ 5DIV or 9DIV). For foot print analyses, the average footprint
area of at least 50 individual O4+ cell or MBP+ cell was measured
by ImageJ fromWT and Cdk5−/− cultures treated with PDGF. Paired
2-way t-tests were used for statistical analysis between treated
and non-treated groups and the signiﬁcance level determined
as Po0.05.Results
Reduction of MBP+ cells during development in Cdk5 knockout
animals
To determine whether the lack of Cdk5 inﬂuenced the devel-
opment of oligodendrocytes, sections through the spinal cord of
wild type and Cdk5−/− littermates were labeled with the antibodies
for OPCs (Olig2) and mature OLs (MBP) and the relative number of
cells assayed. The number of MBP+ cells was reduced in the spinal
cord of Cdk5−/− animals compared to WT littermates at E18
(Fig. 1G, J). For example, the mean number of MBP+ cells/section
in the wild type spinal cord was approximately 5071.8 and this
number was reduced to 1871.6 in Cdk5−/− animals (Fig. 1M). The
distribution of MBP+ oligodendrocytes was also more restricted in
Cdk5−/− animals compared to their wild type littermates. In Cdk5
mutant animals MBP+ cells were primarily localized to ventral
midline regions of the spinal cord, while in littermate controls
MBP+ cells were distributed more widely throughout the dorso-
ventral axis with a higher concentration in ventral regions. The
reduction in the number of MBP+ cells in Cdk5−/− mice was not
a reﬂection of a reduction in progenitor cells since the number
of Olig2+ OPCs was not signiﬁcantly different between WT and
Cdk5−/− animals. Previous studies suggested that Cdk5 regulated
OPC migration (Miyamoto et al., 2008) in vitro, however no
signiﬁcant difference in the distribution of Olig2+ OPCs was
detected between Cdk5-/- and WT animals. These data suggest
that in the absence of Cdk5 the generation of mature oligoden-
drocytes is compromised while the generation of OPCs is relatively
less affected. The transition from OPCs to oligodendrocytes has
been linked to the proliferative status of OPCs and to assess
changes in cell division animals were pulsed with BrdU between
E16-E18 and the average numbers of dividing OPCs in region
matched sections of spinal cord compared between WT and
Cdk5−/− animals. No signiﬁcant differences in OPC proliferation
were apparent between WT (61 BrdU+ cells71.4) and Cdk5−/−
(56 BrdU+ cells71.7) littermates (Fig. 1B and E; H and K)
suggesting the Cdk5 is not required for OPC proliferation and
dispersal but is required for the timely development of mature
oligodendrocytes.
Deletion of Cdk5 in Olig1+ cells results in reduced expression of Mbp
and Plp1
The Cdk5 null animals have multiple defects and die before
birth limiting their usefulness in the analyses of the later stages
Fig. 1. The maturation of spinal cord oligodendrocytes is compromised in the absence of Cdk5 although the proliferation of OPCs is not signiﬁcantly affected. Fig. 1(A–F) At E
18 the relative number of Olig2+ cells is not signiﬁcantly different in the spinal cords of Cdk5−/− animals and WT littermates. Total cell proliferation was also not signiﬁcantly
altered in Cdk5−/− animals. Fig. 1(G–L) The number of MBP+ cells was signiﬁcantly reduced in the spinal cords of Cdk5-/- animals and their distribution was also more
restricted to ventral midline regions. The extent of BrdU incorporation in Olig 2+ and MBP+ cells between WT and Cdk5−/− was not signiﬁcantly different. Fig. 1(M)
Quantitation of the relative numbers of Olig2+, MBP+ and double labeled cells in WT and Cdk5−/− spinal cord sections. The data is taken from at least 4 sections from 3–5
animals in 3 independent experiments L¼ lateral spinal cord, V¼ ventral spinal cord. **po0.05, Scale bar¼25 μm.
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whether the reduction in MBP+ cells in Cdk5−/− animals reﬂected
the loss of Cdk5 function in cells of the oligodendrocyte lineage,
Cdk5 was speciﬁcally deleted in Olig1+ cells using Cre-lox tech-
nology (Fig. 2A). In contrast to Cdk5−/− animals, the Olig1Cre/+;
Cdk5ﬂ/ﬂ (Cdk5 cKO) animals are viable and fertile. Comparison of
the mRNA expression of the myelin components PLP and MBP by
in situ hybridization, however, showed a substantial reduction in
the expression of these myelin genes in Cdk5 cKO animals
compared to littermate controls in the corpus callosum and over-
lying cortex at postnatal day 7 (Fig. 2B–E). This phenotype was not
restricted to early postnatal development, rather comparable
analyses at P14 showed the phenotype to be relatively more
severe than at P7 (Fig. 2F–I). In the P7 spinal cord quantiﬁcation
of plp mRNA positive cells revealed a signiﬁcant reduction in Cdk5
cKO animals (2972.8 in gray matter and 13876.3 in white
matter) compared to WT littermates animals (4973.0 in gray
matter and 20777.6 in white matter, Po0.001; Fig. 2J–L). As in
Cdk5−/− animals, quantitation of the number of PDGFaR+ OPCs and
their relative level of proliferation revealed no signiﬁcant differ-
ences in either the total number of OPCs or their incorporation of
BrdU in Cdk5 cKOs compared to littermate controls (Fig. 2M–Q).
Deletion of Cdk5 in Olig1+ cells results in a reduction of myelinated
axons in Olig1Cre/+;Cdk5ﬂ/ﬂ cKO
The reduction in the number of mature oligodendrocytes
persisted during development, was widespread, and resulted in a
reduction in the level of myelination. In the spinal cord of Olig1Cre/+;
Cdk5 cKO animals in situ hybridization at P14 showed reduced
expression of MBPmRNA compared to littermate controls (Fig. 3A, B).
This reduction was relatively uniform in all regions of the
spinal cord with clear reductions in both dorsal and ventral white
mater suggesting the majority of oligodendrocytes were affectedby the loss of Cdk5. Consistent with the reduction in myelin gene
expression, ultrastructural analysis revealed a signiﬁcant reduction
of myelinated axons and compact myelin in P14 spinal cord of
Olig1Cre/+;Cdk5 cKO compared to littermate controls (Fig. 3C–F).
The relative proportion of myelinated axons was reduced from
44.9%72.4 in control animals to 30.5%72.9 in the Olig1Cre/+;Cdk5
cKO animals (Fig. 3I). Analyses of the g ratios between WT and
Olig1Cre/+;Cdk5 cKO animals revealed a reproducible reduction in
the thickness of myelin sheaths in Olig1Cre/+;Cdk5 cKO animals
(Fig. 3E,F, J). To determine whether the reduction in myelination
was apparent in other white matter regions, the proportion of
myelinated axons was compared in the optic nerves of wild type
and Olig1Cre/+;Cdk5 cKO animals. Consistent with the ﬁndings in
the spinal cord in Olig1Cre/+;Cdk5 cKO animals, an apparent reduc-
tion in the proportion of myelinated axons (5.7%70.6) was seen in
the optic nerve compared to littermate WT (18.3%71.1) controls
(Fig. 3G–J, K) and as in the spinal cord there was an increase in the
g ratio of Olig1Cre/+;Cdk5 cKO optic nerve myelinated axons
(Fig. 3L). Taken together these data suggest Cdk5 is important
for the generation of the correct cohort of oligodendrocytes and
subsequent myelin formation throughout the CNS.
Cdk5 is expressed in the different stages of OPCs and oligodendrocytes
and selectively regulates oligodendrocyte maturation
The reduction in mature oligodendrocytes and myelination
may reﬂect a role for Cdk5 in multiple aspects of oligodendrocyte
development. Characterization of the expression of Cdk5 in cells of
the oligodendrocyte lineage in vitro revealed its expression
throughout oligodendrocyte development in the majority of cells.
In cultures of pan-puriﬁed rat A2B5+ cells virtually all cells
expressed Cdk5 in the perinuclear cytoplasm and in the nucleus
(Fig. 4A–C) and this expression was maintained as the cells
developed into O4+ cells (Fig. 4D–F). Mature oligodendrocytes
Fig. 2. The expression of Mbp and Plp1 mRNA is reduced during postnatal development in Olig1Cre/+; Cdk5ﬂ/ﬂ cKO animals compared to Olig1+/+; Cdk5ﬂ/+ littermate controls. (A) An
outline of the genetic approach of conditional deletion of Cdk5 in olig1+ cells used in the current study. Exons II-V encoding vital Cdk5 catalytic-domain components were ﬂankedwith
loxP elements and excised by Olig1-Cre. (B–E) At P7, in situ hybridization reveals a reduction ofMbp and Plp1mRNA in the corpus callosum and overlying cortex of Olig1Cre/+; Cdk5ﬂ/ﬂ
cKO (C & E) compared to theirWT littermates (B, D). F-I the reduced expression mRNA forMbp and Plp1 is more pronounced at P14 in the corpus callosum of Olig1Cre/+; Cdk5ﬂ/ﬂ cKO
(G, I) compared to their WT littermates (F, H). (J–L) at P7 spinal cord, the total number of plp1+ cells in both gray matter (GM) and white matter (WM) is signiﬁcantly reduced in
Olig1Cre/+; Cdk5ﬂ/ﬂ cKO revealed by in situ hybridization. No signiﬁcant difference is seen in the number of pdgfαR+ OPCs following a 2 h pulse of BrdU by double labeling of BrdU+
(brown)/ pdgfαR+ (blue) cells (arrows) in the cortex (Ctx) and in corpus callosum (CC) between WT (M, O) and Olig1Cre/+; Cdk5ﬂ/ﬂ cKO (N, P). Quantitative data is shown in bar
graphs Q. The data represent the mean7SD taken from at least 8 sections from 3 independent animals of each genotype. Scale bar¼25 μm.
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Fig. 3. Conditional deletion of Cdk5 in Olig1+ cells results in myelination defects. Reduced myelination in the spinal cord and the optic nerve of Olig1Cre/+; Cdk5ﬂ/ﬂ cKO. (A–B)
In situ hybridization of mRNA expression of Mbp shows reduced level in the spinal cord of Olig1Cre/+; Cdk5ﬂ/ﬂ cKO at P14 compared to their WT littermates. (C–J) At P14
Olig1Cre/+; Cdk5ﬂ/ﬂ cKO contained signiﬁcantly reduced number of myelinated axons compared to their WT littermates in both spinal cord (C–F) and the optic nerve (G–J). The
relative thickness of the myelin was also reduced in the Olig1Cre/+; Cdk5ﬂ/ﬂ cKO animals and g ratio for spinal cord and optical nerve axons shows a signiﬁcant reduction in
Olig1Cre/+; Cdk5ﬂ/ﬂ cKO (J, L). Quantitative analysis of the proportion of myelinated axons in the spinal cord and optic nerve at P14 reveals a signiﬁcant reduction in the
absence of Cdk5 in oligodendrocyte lineage cells (I, K). Po0.001. Scale bar¼25 μm.
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Fig. 4. Cdk5 is expressed in cells during multiple distinct stages of development of the oligodendrocyte lineage. (A–C) In puriﬁed primary A2B5+ cell cultures from rat spinal
cord, Cdk5 is expressed in the perinuclear cytoplasm and nuclei (red) of virtually every A2B5+ cell (green). (D–F) Cdk5 (red) is expressed in the majority of O4+ cells (green)
as well as in more mature (G–I) MBP+ cells. (J–L) The expression of Cdk5 in immature cells of the oligodendrocyte lineage is retained in vivowhere Cdk5 (red) is expressed in
NG2+ cells (green) in the spinal cord of adult mouse. Bar¼25 μm.
Y. Yang et al. / Developmental Biology 378 (2013) 94–106100identiﬁed through expression MBP+ also expressed Cdk5 predo-
minantly in their cell bodies (Fig. 4G–I). The expression of Cdk5
was not restricted to cells of the oligodendrocyte lineage during
development but as previously described (Yip et al., 2007) was
also expressed in neurons and NG2+ cells of adult rat spinal cord
(Fig. 4J–L).
While the Olig1 conditional deletion studies strongly implicate
a requirement for Cdk5 in the development of oligodendrocytes
they provide limited insights into which speciﬁc biological pro-
cesses are inﬂuenced. The preferential effect of Cdk5 loss on MBP+
cells in the mutant animals suggests that Cdk5 is predominantly
involved in later stages of oligodendrocyte maturation. Consistent
with this notion treatment of P1 pan-puriﬁed A2B5+ spinal cord
OPCs with the Cdk inhibitor roscovitine (10 mM) (Gray et al., 1999;
Jorda et al., 2012) had a small but not signiﬁcant effect on the
numbers of NG2+ cells (control 15.9%72.1; experimental 10.8%
72.1) and Olig2+ (control 18.6%71.5; experimental 12.4% 71)
cells that developed (Fig. 5A–L, T). By contrast, the number of MBP+
cells that developed was signiﬁcantly reduced in roscovitine treated
cultures compared to controls (control 20.1%71.8: experimental
8.1%71.7, po0.05) (Fig. 5M–R, T). Not only were the numbers
of MBP+ cells reduced but the morphological complexity of the
residual MBP+ cells was also reduced following roscovitine
treatment such that the number of MBP+ cells with long and
complex branched processes or sheets of membrane was decreased
compared to controls (Fig. 5M–R). The reduction in the numberof mature oligodendrocytes in roscovitine treated cultures is not
a consequence of enhanced proliferation of OPC blocking their
differentiation. Pulsing OPC cultures with BrdU for 7 h prior to
analyses revealed and no signiﬁcant changes in the proportion
of NG2+ (control 21.2%72.1: experimental 20%72.3) or Olig2+
(control 19.2%71.9: experimental 17.1%72.2) OPCs that incorpo-
rated BrdU compared to controls (Fig. 5S, n¼3) suggesting that
Cdk5 is not critical for OPC proliferation but, rather is important
for the transition of newly formed oligodendrocytes to mature
oligodendrocytes.
Knockdown of endogenous Cdk5 delays oligodendrocyte maturation
while over-expression of Cdk5 promotes MBP+ cell appearance
The roscovitine studies suggest that kinase activity is important
for the maturation of oligodendrocytes. To deﬁne the speciﬁc role
of Cdk5 in oligodendrogenesis, Cdk5 was targeted by RNAi in
spinal cord mixed cell cultures via electroporation using Amaxa
Neucleitransfector and the development of oligodendrocytes were
assessed. In cultures transfected with Cdk5 RNAi endogenous Cdk5
was markedly down-regulated after 2 days (Fig. 6Ab-b″) while in
control cultures the majority of cells expressed Cdk5 (Fig. 6Aa-a″),
indicating that the Cdk5 RNAi effectively suppresses endogenous
Cdk5 expression. Analysis of the oligodendrocyte development in
Cdk5 RNAi treated cultures demonstrated that the complexity of
the processes of O4+ cells lacking Cdk5 was reduced, resulting in
Fig. 5. Blocking Cdk5 with roscovitine inhibits oligodendrocyte maturation but does not affect OPC proliferation. (A–F) The number of NG2+ cells present in A2B5 pan
puriﬁed cell cultures was only slightly reduced following inhibition of Cdk5 activity for 4 days by treatment with roscovitine and their proliferation as measured by
incorporation of BrdU was not signiﬁcantly different. (G–L) The number of Olig2+ cells present in A2B5 pan puriﬁed cell cultures was slightly reduced following inhibition
of Cdk5 activity for 4 days by treatment with roscovitine and their proliferation as measured by incorporation of BrdU was not signiﬁcantly different. (M–R) the number of
MBP+ cells that developed in A2B5 pan puriﬁed cell cultures was signiﬁcantly reduced following inhibition of Cdk5 activity for 4 days by treatment with roscovitine. The
morphology of MBP+ cells in roscovitine treated cultures was notably less complex that in vehicle treated control cultures. The cells contained fewer processes and lacked
characteristic membrane sheets of mature MBP+ cells. Quantitation is shown in histogram (S, T) and represents the mean7SD taken from at least 3 independent coverslips
form 3 different experiments. Bar¼25 μm.
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Fig. 6. The maturation of oligodendrocytes is modulated by knockdown or overexpression of Cdk5 in spinal cord cultures. (A) In spinal cord cultures, cells transfected with
RNAi for Cdk5. (Ab-b″) showed approximately 98% endogenous Cdk5 knockdown compared with cells transfected with empty-vector (EGFP-C3) as a control (Aa-a″). (B) The
morphological complexity of cells transfected with control (Ba-a″) constructs was signiﬁcantly more pronounced than cells transfected with Cdk5 RNAi (Bb-b″) (green) and
co-labeled with O4+ (red) and MBP+ (red) (Bc-d″). Cdk5 RNAi transfected cells had shorten processes and a less complex morphology compared to control cells. (Be-e″) Cells
that escaped Cdk5 knockdown retained a complex morphology in experimental cultures demonstrating the speciﬁcity to the Cdk5 effect. (C) Over expression of Cdk5 results
in increased complexity of cultured O1+ (Cb-b″) and MBP+ oligodendrocytes (Cd-d″). More than 6% of the MBP+ cells had an increased complexity of their processes in
cultures driven to overexpress Cdk5-EGFP compared to control. Quantitative data were shown in graphics. Scale bar¼25 μm.
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similar reduction in the complexity of MBP+ cell processes was
seen in MBP+ cells following Cdk5 RNAi treatment (Fig. 6Bc-c″).
Oligodendrocytes in the cultures that escaped electroporation
retained Cdk5 expression and developed normal process arboriza-
tions (Fig. 6Be-e″). These ﬁndings are consistent with the effects
of pharmacological inhibition of Cdk5 and suggest that it plays a
critical role in regulating oligodendrocytes development and
maturation. Quantiﬁcation of the proportion of Cdk5+/MBP+ cells
demonstrated a signiﬁcant decrease in cells subjected to Cdk5
knockdown compared to controls (Fig. 6D). While not all cells
in the cultures had reduced expression of Cdk5 none of the
cells that lacked Cdk5 had detectable expression of MBP, while
cells that retained Cdk5 exhibited normal MBP expression, sug-
gesting reduced or delayed maturation of oligodendrocytes in the
absence of Cdk5.
To determine whether increasing the expression of Cdk5
enhanced the maturation of oligodendrocytes, cultures weretransfected with Cdk5-EGFP (Fig. 6C) or a randomly scrambled
siRNA (not shown) and labeled with O1+ or anti-MBP+ antibodies.
Overexpression of Cdk5 resulted in O1 and MBP+ cells with a more
mature morphology including more highly branched processed
and sheets of membrane (Fig. 6Cb-b″ and Cd-d″) compared to
cells transfected with a control construct containing only EGFP
(Fig. 6Ca-a″ and Cc-c″). Quantitative analysis demonstrated that
approximately 10% of the MBP+ cells had complex morphology in
the culture transfected with Cdk5-EGFP, while less than 4% of MBP+
cells had the mature phenotype in control cultures.
The extent of oligodendrocyte process outgrowth and branching is
signiﬁcantly reduced in the absence of Cdk5
To assess in more detail the effects of Cdk5 on the elaboration of
a mature morphological oligodendrocyte phenotype, the morphol-
ogy of WT and Cdk5−/− cells was compared in vitro. While there
was no signiﬁcant difference in the proportion of O4+ or O1+
Fig. 7. Absence of Cdk5 results in a speciﬁc reduction in the extent of mature oligodendrocyte processes outgrowth and branching. (A) Brain mixed dissociated cell cultures
fromWT and E18 Cdk5 KOwere labeled with O4, O1 and MBP antibodies at 2.5, 7 and 9 days in vitro (DIV) respectively. Although a slight reduction in the proportion O4+ or
O1+ oligodendrocytes in Cdk5−/− cultures was seen it was not signiﬁcant (7A a–d). By contrast, the number of MBP+ cells was signiﬁcantly reduced in Cdk5−/− cultures (7A e–f).
Quantiﬁcation shows in (7A g). A slight reduction in the number of processes and the extent of branching in O4+ of Cdk5−/− cells but a robust reduction of the number of
processes and the extent of branching in MBP+ cells that developed in Cdk5−/− cultures compared to WT (Fig. 7A h). nnnpo0.001. (B) The perturbed development of
oligodendrocytes in the absence of Cdk5 is not rescued by addition of exogenous PDGF in spinal cord explant cultures. (a, b) Addition of exogenous PDGF (10 ng/ul) in spinal
cord explant culture of E18 Cdk5−/− did not enhance the number or morphology of O4+ cells in Cdk5−/− cultures compared to Cdk5+/+. (c, d) Addition of exogenous PDGF did
not signiﬁcantly alter the morphology or the number of MBP+ cell that developed in explant cultures of E18 Cdk5−/− animals. Quantitative analysis of the average footprint
for individual MBP+ cells from WT or Cdk5−/− animals treated with PDGF treatment showed a substantially smaller footprint from Cdk5−/− cells (Fig. 7B e). Scale bar¼25 μm
in A and B.
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(a–d)) the number of MBP+ cells was signiﬁcantly reduced (Fig. 7A
(e–f)). With maturation, oligodendrocytes acquire an increasingly
complex morphology and while a slight reduction in the number
of process and the extent of branching was apparent in O4+ cell
lacking Cdk5 the effect was signiﬁcantly more pronounced in
mature MBP+ cells (Fig. 7A(e–f)). For examples while control MBP
+ cells had a mean of 5.170.3 primary process and 19.871.5
branches, Cdk5−/− cells had a mean of 3.470.23 primary process
and 9.470.75 branches.PDGF does not rescue reduced oligodendrocyte maturation in Cdk5-/-
E18 spinal cord explant culture
One possible mechanism that might account for the perturba-
tion of oligodendrocyte differentiation in the absence of Cdk5 is a
limited response to PDGF, a major OPC mitogen and survival factor
for newly generated oligodendrocytes (Raff et al., 1988; Richardson
et al., 1988). To determine if the lack of mature oligodendrocytes in
Cdk5−/− animals could be reversed by exposure to PDGF, spinal
cord explants from WT and Cdk5−/− animals were grown in the
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PDGF failed to rescue the perturbed development or morphology
of oligodendrocytes in Cdk5−/− cultures. The number of O4+ and
MBP+ cells was decreased in Cdk5−/− derived culture compared to
WT (Fig. 7B(b and d)) and the MBP+ cells that did develop had few
short processes (Fig. 7B(d)) compared to the morphology of WT
MBP+ cells that possessed long highly branched processes (Fig. 7B
(c)). The quantitative analysis of average footprint for individual
MBP+ cells of WT or Cdk5−/− with PDGF treatment showed a
substantial decrease with Cdk5−/− cells (Fig. 7B(e)). The reduction
in the number and morphological complexity of O4+ cells in these
Cdk5−/− cultures likely reﬂects the overlapping expression of O4
and MBP with the extended culture period. Taken together these
results suggest that lack of Cdk5 activity effects the maturation of
oligodendrocytes and their ability to myelinate on schedule.Discussion
The molecular mechanisms mediating the development of
oligodendrocytes are highly complex with multiple growth factors
and extracellular signals regulating the induction, proliferation,
migration, differentiation of OPCs and maturation of oliogoden-
drocytes. How these signals are integrated within the cells to
inﬂuence their biology is not well understood. Here we show that
the intracellular signaling molecule Cdk5 plays an important role
in regulating the appearance of oligodendrocytes at a speciﬁc
stage in their development. In Cdk5 null animals during embryo-
nic development the number and distribution of mature oligoden-
drocytes is signiﬁcantly reduced in the spinal cord. In aged-
matched WT animals MBP+ cells are localized in the ventral
midline of the spinal cord as well as more laterally while in
Cdk5 null animals they are restricted to midline regions. Further-
more, while the number and distribution of Olig2+ progenitor
cells is relatively unaffected, the number of MBP+ cells is sig-
niﬁcantly reduced in Cdk5 null animals throughout development.
The reduction in mature oligodendrocytes is not a reﬂection of
reduced proliferation by OPCs since the proportion of BrdU+ cells
was not signiﬁcantly different between Cdk5−/− and wild type
animals. Consistent with these data, conditional deletion of Cdk5
from olig1+ cells resulted in reduced expression of MBP and PLP in
postnatal animals although there was no obvious effect in the
number of PDGFαR+ cells or their proliferation in either white or
gray matter. The reduction in myelin gene expression is reﬂected
in a reduction in the level of myelination in both the spinal cord
and the optic nerve that remains pronounced until at least the
second postnatal week. Analysis of the expression and function of
Cdk5 expression in cells of the oligodendrocyte lineage revealed
its expression in both early and late stages of the oligodendrocyte
lineage. Both kinase inhibition and RNAi-induced knockout down
of Cdk5 impaired the biochemical and morphological maturation
of oligodendrocytes, while over expression of Cdk5 resulted in
more robust oligodendrocyte maturation. Morphological analyses
of cultured oligodendrocytes demonstrated a reduction in the
number of primary processes and branching in the absence of
Cdk5 that correlated with reduced expression of MBP. Thus, in the
oligodendrocyte lineage the primary role of Cdk5 appears to be to
modulate maturational and morphological changes in oligoden-
drocytes rather than the cell division kinetics of the OPC
population.
One common linkage between many of the biological phenom-
ena impacted by Cdk5 in neuronal cells is a connection to cell
polarity and motility (Morﬁni et al., 2004). Previous in vitro studies
suggested that Cdk5 modulates OPC migration (Miyamoto et al.,
2008), however the distribution of OPCs in the developing spinal
cord was not signiﬁcantly different in transgenic animals lackingCdk5 indicating that it is not essential for OPC dispersal in vivo.
Rather we propose that a dysregulation of cell polarity and
motility events underlie the disruption of maturation of oligoden-
drocytes devoid of Cdk5. Several lines of evidence are consistent
with this hypothesis. First in Cdk5 null animals the appearance of
MBP+ cells in the embryonic spinal cord is reduced and more
restricted than in wild type littermates, implicating a maturational
defect. Second, the reduction in the complexity of Cdk5 null
oligodendrocytes and the reduced length of their processes
compared to wild type cells suggests that oligodendrocyte process
extension is compromised in the absence of Cdk5. This is remi-
niscent of the lack of axonal growth seen in neurons lacking Cdk5
(Fang et al., 2011; Hahn et al., 2005). One potential mechanism for
the modulation of oligodendrocyte process development seen in
the absence of Cdk5 may be phosphorylation of the paxillin by
Cdk5 that inﬂuence paxillin's association with the focal adhesion
kinase (FAK) in an oligodendrocyte cell line (Miyamoto et al.,
2007). Whether similar signaling pathways are operative in
primary oligodendrocytes is currently unclear. Finally, the reduc-
tion in myelination in Cdk5 null animals may also reﬂect the
reduction in the cellular polarity or motility of the myelinating
processes. Indeed, the mechanics of the initiation of myelination
are still not well understood, although it is clear they reﬂect the
polarization of oligodendrocytes, the compartmentalization of the
membrane domains and the motility of the myelinating process
(Kippert et al., 2007).
While alterations in the morphology and myelination of Cdk5
null oligodendrocytes are consistent with changes in cell motility,
the reduction in expression of MBP is less easily explained. It may
be, however that the reduction in MBP expression is also a direct
effect of modulation of intracellular motile activity in the absence
of Cdk5. Earlier studies demonstrated that the mRNA for MBP is
not located in the cytoplasm adjacent to the oligodendrocyte
nucleus, but rather is transported to the terminal of the processes
where it is translated into protein that is locally inserted into the
membrane (Boccaccio et al., 1999; Boccaccio and Colman, 1995).
The mechanisms of mRNA transport have been extensively studied
and the data support a hypothesis in which clusters of mRNAs are
transported along microtubules through the activity of kinesins
and dyneins (Carson et al., 1998; Carson et al., 1997; Shan et al.,
2003). This activity is likely a consequence of cell polarization and
has recently been shown to be regulated both by adapter proteins
such as heterogeneous nuclear ribonucleoprotein (hnRNP) (White
et al., 2012). This intracellular transport, similar to fast axonal
transport, (Drake et al., 1985) also occurs in neurons where it
targets dendritic RNAs to post synaptic sites. In neurons, retro-
grade transport of proteins important in polarity and migration
such as LIS1 and NDEL is dependent on the activity of Cdk5 and
this related intracellular transport is completely blocked in cul-
tured neurons treated with a dominant negative Cdk5 (Pandey and
Smith, 2011). Based on these data we propose that the disruption
in the maturation of oligodendrocytes in the absence of Cdk5 is
largely a reﬂection of perturbed transport and targeting of mRNAs
including MBP that are essential for directed oligodendrocyte
precursor migration, process outgrowth and myelination.
Recent studies have begun to reveal the distinct roles for
different intracellular signaling pathways in the maturation of
oligodendrocytes and myelination. For example, over expression of
AKT1 in oligodendrocytes and their precursors via the PLP pro-
moter results in exuberant production of myelin in the CNS that
ultimately results in axonal compression and death suggesting
that signaling through the AKT pathway selectively regulates the
extent of myelination in oligodendrocytes rather than in cell death
as it does in many other cell types (Narayanan et al., 2009; Tyler
et al., 2009). Consistent with a role for AKT signaling in modulating
myelination inhibition of mTOR by rapamycin treatment results in
Y. Yang et al. / Developmental Biology 378 (2013) 94–106 105a blockade in oligodendrocyte development (Gomez et al., 2011;
Guardiola-Diaz et al., 2012). By contrast, inhibition of the ERK
pathway alters the timing of myelination in the CNS (Fyffe-
Maricich et al., 2011) and possibly more importantly reduces the
thickness of the myelin sheaths that develop around large dia-
meter axons. Like Cdk5 neither the AKT nor ERK pathways appear
to be essential for the proliferation of OPCs. Rather OPC prolifera-
tion may be mediated predominantly by p38 kinase (Chew et al.,
2010). Further studies are required to deﬁne the interactions
between AKT and ERK signaling and Cdk5.
In conclusion our studies demonstrate an important role for
Cdk5 in the development of oligodendrocytes and myelination.
Several intracellular pathways converge on Cdk5 and future
studies will be directed at deﬁning which of these pathways are
essential for the timely myelination and myelin repair after injury.Acknowledgments
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